Loading company…
Time Prediction develops iPSC-based diagnostic technology and tools for neurological disease prediction.
Time Prediction develops digital iPSC technology and diagnostic tools for neurological diseases, including Time iScan for early diagnosis support and Time gScan for ultra-early Alzheimer's disease prediction. Founded in 2021, the company is based in Japan and was led by president and CEO Tomoko Tada as of 2023. In December 2024, it raised JPY 60 million from Incubate Fund to develop ALS early diagnosis support using iPS cells and AI.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in